Atlas Trials

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

Clinical trial NCT03086538 · COMPLETED

Trial details

NCT number
NCT03086538
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colo-rectal Cancer
Start date
2017-05-30
Primary completion
2020-01-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.